DK1137786T3 - Viruscoatprotein/receptorkimærer og fremgangsmåder til brug heraf - Google Patents

Viruscoatprotein/receptorkimærer og fremgangsmåder til brug heraf

Info

Publication number
DK1137786T3
DK1137786T3 DK00968759T DK00968759T DK1137786T3 DK 1137786 T3 DK1137786 T3 DK 1137786T3 DK 00968759 T DK00968759 T DK 00968759T DK 00968759 T DK00968759 T DK 00968759T DK 1137786 T3 DK1137786 T3 DK 1137786T3
Authority
DK
Denmark
Prior art keywords
receptor
virus
methods
chimeric
coating protein
Prior art date
Application number
DK00968759T
Other languages
English (en)
Inventor
Anthony Louis Devico
Timothy R Fouts
Robert G Tuskan
Original Assignee
Univ Maryland Biotech Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland Biotech Inst filed Critical Univ Maryland Biotech Inst
Application granted granted Critical
Publication of DK1137786T3 publication Critical patent/DK1137786T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK00968759T 1999-10-08 2000-10-06 Viruscoatprotein/receptorkimærer og fremgangsmåder til brug heraf DK1137786T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15832199P 1999-10-08 1999-10-08
PCT/US2000/027546 WO2001027294A1 (en) 1999-10-08 2000-10-06 Virus coat protein/receptor chimeras and methods of use

Publications (1)

Publication Number Publication Date
DK1137786T3 true DK1137786T3 (da) 2007-08-06

Family

ID=22567583

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00968759T DK1137786T3 (da) 1999-10-08 2000-10-06 Viruscoatprotein/receptorkimærer og fremgangsmåder til brug heraf

Country Status (9)

Country Link
EP (1) EP1137786B1 (da)
AT (1) ATE358726T1 (da)
AU (1) AU7862500A (da)
CY (1) CY1106691T1 (da)
DE (1) DE60034211T2 (da)
DK (1) DK1137786T3 (da)
ES (1) ES2284532T3 (da)
PT (1) PT1137786E (da)
WO (1) WO2001027294A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040076636A1 (en) * 1993-05-07 2004-04-22 Ranajit Pal HIV immunogenic complexes
US6908612B2 (en) * 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US7811580B2 (en) 2002-05-07 2010-10-12 Novartis Vaccines & Diagnostics, Inc. Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
WO2004073603A2 (en) * 2003-02-14 2004-09-02 Aeras Global Tuberculosis Vaccine Foundation Dna vaccine that expresses mutant adp-ribosyltransferase toxins which display reduced, or are devoid of, adp-ribosyltransferase activity
CA2719522A1 (en) * 2007-03-26 2008-10-02 University Of Maryland, Baltimore A non-destructive method to quantify and isolate antigen-specific b cells and uses thereof
WO2014055413A2 (en) * 2012-10-02 2014-04-10 Bloodcenter Research Foundation A method of providing cellular therapy using modified natural killer cells or t lymphocytes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT89484B (pt) * 1988-01-22 1994-03-31 Gen Hospital Corp Genes clonados codificadores de proteinas de fusao ig-cd4 e sua utilizacao
EP0550516A1 (en) * 1990-09-28 1993-07-14 Hospital For Joint Diseases Method for inhibiting the infectivity of human immunodeficiency virus
DE69328726D1 (de) * 1992-02-10 2000-06-29 Univ Durham Verwendung synthetischer peptide zur induktion der toleranz gegen t- und b-zell epitope von autoantigenen
ATE207760T1 (de) * 1993-05-07 2001-11-15 Akzo Nobel Nv Hiv immunogene komplexe
AU7127798A (en) * 1997-04-18 1998-11-13 President And Fellows Of Harvard College Bifunctional polypeptides for cell-specific viral targeting

Also Published As

Publication number Publication date
CY1106691T1 (el) 2012-05-23
DE60034211D1 (de) 2007-05-16
PT1137786E (pt) 2007-07-13
EP1137786A1 (en) 2001-10-04
ES2284532T3 (es) 2007-11-16
WO2001027294A1 (en) 2001-04-19
DE60034211T2 (de) 2007-12-20
WO2001027294A9 (en) 2002-05-16
AU7862500A (en) 2001-04-23
EP1137786B1 (en) 2007-04-04
ATE358726T1 (de) 2007-04-15

Similar Documents

Publication Publication Date Title
WO2003016333A3 (en) Virus coat protein/receptor chimeras and methods of use
Trkola et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
LaBonte et al. Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells
Chanh et al. Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response
CA2681922A1 (en) Zinc finger protein derivatives and methods therefor
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
CA2395291A1 (en) Five-helix protein
RU2003108736A (ru) Способы стабильной трансдукции клеток вирусными векторами
WO2007149491A3 (en) Soluble stabilized trimeric hiv env proteins and uses thereof
DK33190A (da) Hiv-3 retrovirus og anvendelse heraf
WO1998009642A3 (en) Therapeutic chemokine antagonists
Cole et al. Retrocyclins: using past as prologue
CY1106691T1 (el) Πρωτεϊνη του καψιδιου ιου/χιμαιρες υποδοχεα και μεθοδοι χρησης
EP2339010A3 (en) Lentiviral vector particles resistant to complement inactivation
EP2305818A3 (en) Antigen constructs useful in the detection and differentiation of antibodies to HIV
DK0975783T3 (da) Retrovirusvektorer, fremgangsmåde til fremstilling heraf samt deres anvendelse til genoverføring til CD4-positive celler
WO1999006561A3 (en) Chemokine receptor ccr8 dna and uses thereof
EP3202410B1 (en) Methods and compositions for treating hiv
WO2001016182A3 (en) POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE
WO2007024976A3 (en) Virus coat protein/receptor chimeras and methods of use
WO2000049038A3 (de) Synthetische peptide des regulatorischen virusproteins r (vpr) des humanen immundefizienzvirus typ 1 (hiv-1) und ihre verwendung
WO2002069691A3 (en) Immunogenic hiv peptides for use as reagents and vaccines
CA2431881A1 (en) Polypeptide inducing hiv-neutralising antibodies
Marques HIV-1 Rev C-terminal domain is important for Rev function restriction in murine A9 cells (Immune deficiency)
WO2004104031A2 (en) Modified antiviral peptides with increased activity and cell membrane affinity